Glenmark Pharmaceuticals
 | |
| Public company | |
| Traded as |
BSE: 532296 NSE: GLENMARK) |
| Industry | Pharmaceuticals |
| Founded | 1977 |
| Founders | Gracias Saldanha |
| Headquarters | Mumbai, Maharashtra[1], India |
Area served | Global |
Key people | Glenn Saldanha, MD & Chairman[2] |
| Products | Medicines and Vaccines |
| Revenue | USD 1.2 billion [3] |
Number of employees | Over 12,000 [4] |
| Website | www.glenmarkpharma.com |
Glenmark Pharmaceuticals is a pharmaceutical company headquartered in Mumbai, India.[5] It is a research driven global pharmaceutical organization focused on discovering novel molecules and developing high-quality generics and specialty products for markets across the globe.[6]
Glenmark has 17 manufacturing facilities across 5 countries including US, Switzerland, Argentina, Czech Republic and India.[7] Glenmark has 5 R&D centers around the world engaged in discovery of novel biological and chemical entities.
References
- ↑ http://www.glenmarkpharma.com/UITemplate/HtmlContainer.aspx?res=P_GLN_CONTACT
- ↑ (PDF) http://www.glenmarkpharma.com/sites/default/files/Profile%20Glenn%20Saldanha.pdf. Missing or empty
|title=(help) - ↑ http://www.bseindia.com/stock-share-price/glenmark-pharmaceuticals-ltd/glenmark/532296/
- ↑ "Glenmark Pharmaceuticals Ltd. (2529483): Stock Quote & Company Profile – BusinessWeek". Investing.businessweek.com. Retrieved 30 September 2010.
- ↑ "about Glenmark Pharmaceuticals" (PDF). ibef.org. Retrieved 30 September 2010.
- ↑ http://www.glenmarkpharma.com/about-us/overview
- ↑ http://www.glenmarkpharma.com/formulations/formulations-manufacturing-facilities
This article is issued from Wikipedia - version of the 11/20/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.